Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Paratek Pharma Inc (PRTK)

Paratek Pharma Inc (PRTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 127,828
  • Shares Outstanding, K 57,322
  • Annual Sales, $ 160,270 K
  • Annual Income, $ -63,570 K
  • EBIT $ -45 M
  • EBITDA $ -44 M
  • 60-Month Beta 1.70
  • Price/Sales 0.78
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.10
  • Most Recent Earnings $-0.25 on 08/03/23
  • Next Earnings Date 11/02/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 0.009 on 10/31/14
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.25
  • Number of Estimates 2
  • High Estimate -0.24
  • Low Estimate -0.25
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +34.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.17 +2.76%
on 08/21/23
2.24 -0.45%
on 09/20/23
+0.02 (+0.90%)
since 08/18/23
3-Month
2.17 +2.76%
on 08/21/23
2.24 -0.45%
on 09/20/23
+0.04 (+1.83%)
since 06/20/23
52-Week
1.29 +72.87%
on 03/16/23
3.65 -38.90%
on 11/01/22
-0.17 (-7.08%)
since 09/20/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, NEWR, PRTK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AEL : 56.47 (+0.55%)
NEWR : 86.99 (+0.02%)
PRTK : 2.23 (+1.83%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Paratek Pharmaceuticals, Inc. by Gurnet Point Capital

/PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Paratek Pharmaceuticals, Inc....

PRTK : 2.23 (+1.83%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRTN, AMED, PRTK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TRTN : 79.55 (-4.10%)
AMED : 90.97 (+0.36%)
PRTK : 2.23 (+1.83%)
Paratek: Q2 Earnings Snapshot

Paratek: Q2 Earnings Snapshot

PRTK : 2.23 (+1.83%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRTK, PTEN, NEX, BG

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PRTK : 2.23 (+1.83%)
PTEN : 8.62 (-0.69%)
NEX : 10.61 (+0.95%)
BG : 88.44 (+0.90%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Paratek Pharmaceuticals, Inc. by Gurnet Point Capital

/PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Paratek Pharmaceuticals, Inc....

PRTK : 2.23 (+1.83%)
NexPoint Sends Demand Letter for Books and Records to Paratek Pharmaceuticals in Connection with Proposed Acquisition by Gurnet Point Capital

/PRNewswire/ -- NexPoint Event Driven Fund today issued a demand letter to the Board of Directors of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) (the...

PRTK : 2.23 (+1.83%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, PTEN, NEX, PRTK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NETI : 11.33 (+0.09%)
PTEN : 8.62 (-0.69%)
NEX : 10.61 (+0.95%)
PRTK : 2.23 (+1.83%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates WMC, SGTX, PRTK

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WMC : 9.18 (+4.44%)
SGTX : 22.47 (-2.56%)
PRTK : 2.23 (+1.83%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates QUOT, PRTK, TESS, HMPT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

QUOT : 3.99 (unch)
PRTK : 2.23 (+1.83%)
TESS : 8.99 (+0.11%)
HMPT : 2.32 (unch)

Business Summary

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapeutics that treat infectious disease agents. The Company's lead product candidate, omadacycline, is a tetracycline-derived antibiotic being developed for use...

See More

Key Turning Points

3rd Resistance Point 2.30
2nd Resistance Point 2.27
1st Resistance Point 2.25
Last Price 2.23
1st Support Level 2.20
2nd Support Level 2.17
3rd Support Level 2.15

See More

52-Week High 3.65
Fibonacci 61.8% 2.75
Fibonacci 50% 2.47
Last Price 2.23
Fibonacci 38.2% 2.19
52-Week Low 1.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar